#United States #AI Technology #Clinical Trials #Conshohocken #Suvoda

Major Update to Suvoda's Clinical Trial Platform

Suvoda has recently announced a substantial update to its renowned clinical trial platform, aiming to enhance the global experience for clinical studies by integrating cutting-edge technology and streamlining various processes involved. This update comes after the successful unification of Suvoda's and Greenphire's leading market products into a singular, comprehensive platform that significantly improves efficiency and reduces the manual workload for users.

Innovations That Make a Difference

The newly integrated platform offers a plethora of new features aimed at optimizing clinical trials. It adeptly connects critical technologies and services throughout the various phases of a clinical trial, giving sponsors, contract research organizations (CROs), research sites, and patients the essential tools they need for informed decision-making and quicker processes.

One of the major challenges historically faced in clinical trials was the disjointed nature of systems requiring integration across various providers and technologies. This fragmentation often forced study teams to engage with multiple systems for randomization, drug supply management, survey completion, payments, patient consent, and travel arrangements. Suvoda's latest update transforms this experience into a cohesive and user-friendly platform.

Integrated AI Capabilities

With this update, Suvoda is introducing AI capabilities throughout its platform, starting with Randomization and Trial Supply Management (RTSM) and Electronic Clinical Outcome Assessment (eCOA), and extending to financial services such as patient payments. This incorporation of artificial intelligence is proving to be game-changing, with evidence showing up to an 80% reduction in timelines from project initiation to user acceptance testing (UAT). The AI assistant, Sofia, offers multilingual support for sponsors and research sites, allowing them to search and execute authorized actions seamlessly; all actions performed are documented for compliance audits.

Unified Sign-On for Multiple Products

Another significant feature of the updated platform is the introduction of a single sign-on that connects eight essential products. This innovation allows study teams to transition seamlessly among RTSM/IRT, eCOA, eConsent, and other services without the hassle of switching systems. A unified data layer ensures that participant data, once entered in the RTSM, automatically flows between products, eliminating duplicate entries and potential errors.

Enhancing Decision-Making

These updates have greatly improved rapid decision-making capabilities for sponsors and CROs. The enhanced reporting and self-service features allow stakeholders to independently access study data as needed. The Budgeting Benchmarking tool now enables negotiations directly on the platform, making financial processes more efficient and insightful, with timely updates based on payment data contours.

Improved Patient Experience

Moreover, the award-winning Suvoda App continues to provide patients with an optimal user experience where they can track visits, request transportation, complete surveys, and receive micropayments upon task completion. Enhanced features facilitate video calls for home visits and allow sites to share their availability, thus simplifying appointment scheduling. Patients globally can enjoy hassle-free reimbursement processes via their preferred payment methods, including digital wallets such as Alipay in China. This results in reduced inquiries regarding payment statuses and less manual data transfer for research sites.

A Vision for the Future

Jagath Wanninayake, CEO of Suvoda, expressed pride in the advancements achieved through this launch. He emphasized that the integrated platform, powered by AI, enables centers to focus more on essential tasks rather than reconciling disparate systems. Patients benefit from a significantly improved trial experience, and sponsors can obtain quicker, more reliable responses to critical queries.

In conclusion, Suvoda is on a mission to redefine how clinical trials are conducted worldwide. By leveraging innovative technology and a commitment to enhancing trial processes for all involved, the company continues to pave the way for breakthroughs that could reshape patient care and clinical outcomes in the years to come. For more information, visit suvoda.com and follow Suvoda on LinkedIn.